Xtant Days Of Payables Outstanding from 2010 to 2024

XTNT Stock  USD 0.93  0.02  2.11%   
Xtant Medical Days Of Payables Outstanding yearly trend continues to be comparatively stable with very little volatility. Days Of Payables Outstanding is likely to outpace its year average in 2024. From the period from 2010 to 2024, Xtant Medical Days Of Payables Outstanding quarterly data regression had r-value of (0.31) and coefficient of variation of  46.90. View All Fundamentals
 
Days Of Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
71.84702534
Current Value
119.72
Quarterly Volatility
41.66255952
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many exotic indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
This module can also supplement various Xtant Medical Technical models . Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Days Of Payables Outstanding Growth Pattern

Below is the plot of the Days Of Payables Outstanding of Xtant Medical Holdings over the last few years. It is Xtant Medical's Days Of Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Days Of Payables Outstanding10 Years Trend
Slightly volatile
   Days Of Payables Outstanding   
       Timeline  

Xtant Days Of Payables Outstanding Regression Statistics

Arithmetic Mean88.84
Geometric Mean79.49
Coefficient Of Variation46.90
Mean Deviation35.40
Median82.17
Standard Deviation41.66
Sample Variance1,736
Range133
R-Value(0.31)
Mean Square Error1,693
R-Squared0.09
Significance0.27
Slope(2.86)
Total Sum of Squares24,301

Xtant Days Of Payables Outstanding History

2024 119.72
2023 71.85
2022 49.31
2021 41.91
2020 44.1
2019 36.03
2018 82.17

About Xtant Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Xtant Medical income statement, its balance sheet, and the statement of cash flows. Xtant Medical investors use historical funamental indicators, such as Xtant Medical's Days Of Payables Outstanding, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may use each financial statement separately, they are all related. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Xtant Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Xtant Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Xtant Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Payables Outstanding 71.85  119.72 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Xtant Medical Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Xtant Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Xtant Medical Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Xtant Medical Holdings Stock:
Check out the analysis of Xtant Medical Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Xtant Stock analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.01
Revenue Per Share
0.767
Quarterly Revenue Growth
0.841
Return On Assets
(0.08)
Return On Equity
0.0154
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.